Cargando…
A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831)
Clinical diagnoses of Attention Deficit Hyperactivity Disorder (ADHD) and the use of prescription medications for its treatment have increased in recent years. Current treatments may involve the administration of amphetamine-type substances, a treatment path many parents are apprehensive to take. Th...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690059/ https://www.ncbi.nlm.nih.gov/pubmed/26633481 http://dx.doi.org/10.3390/nu7125507 |
_version_ | 1782406944889241600 |
---|---|
author | Kean, James D. Kaufman, Jordy Lomas, Justine Goh, Antionette White, David Simpson, David Scholey, Andrew Singh, Hemant Sarris, Jerome Zangara, Andrea Stough, Con |
author_facet | Kean, James D. Kaufman, Jordy Lomas, Justine Goh, Antionette White, David Simpson, David Scholey, Andrew Singh, Hemant Sarris, Jerome Zangara, Andrea Stough, Con |
author_sort | Kean, James D. |
collection | PubMed |
description | Clinical diagnoses of Attention Deficit Hyperactivity Disorder (ADHD) and the use of prescription medications for its treatment have increased in recent years. Current treatments may involve the administration of amphetamine-type substances, a treatment path many parents are apprehensive to take. Therefore, alternative pharmacological treatments are required. Few nutritional or pharmacological alternatives that reduce ADHD associated symptoms (hyperactivity and inattention) have been subjected to rigorous clinical trials. Bacopa monnieri is a perennial creeping herb. CDRI 08 is a special extract of Bacopa monnieri which has been subjected to hundreds of scientific studies and has been shown in human randomized controlled trials (RCTs) to improve memory, attention, and mood. It is hypothesised that chronic administration of CDRI 08 will improve attention, concentration and behaviour in children with high levels of hyperactivity and/or inattention. This paper reports the protocol for the first 16-week, randomized, placebo-controlled, double-blind, parallel groups trial examining the efficacy and safety of CDRI 08 in male children aged 6–14 years with high levels of inattention and hyperactivity. The primary outcome variable will be the level of hyperactivity and inattention measured by the Conners’ Parent Rating Scale (CPRS). Secondary outcome variables include cognition, mood, sleep, and EEG. Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12612000827831. |
format | Online Article Text |
id | pubmed-4690059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-46900592015-12-30 A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) Kean, James D. Kaufman, Jordy Lomas, Justine Goh, Antionette White, David Simpson, David Scholey, Andrew Singh, Hemant Sarris, Jerome Zangara, Andrea Stough, Con Nutrients Communication Clinical diagnoses of Attention Deficit Hyperactivity Disorder (ADHD) and the use of prescription medications for its treatment have increased in recent years. Current treatments may involve the administration of amphetamine-type substances, a treatment path many parents are apprehensive to take. Therefore, alternative pharmacological treatments are required. Few nutritional or pharmacological alternatives that reduce ADHD associated symptoms (hyperactivity and inattention) have been subjected to rigorous clinical trials. Bacopa monnieri is a perennial creeping herb. CDRI 08 is a special extract of Bacopa monnieri which has been subjected to hundreds of scientific studies and has been shown in human randomized controlled trials (RCTs) to improve memory, attention, and mood. It is hypothesised that chronic administration of CDRI 08 will improve attention, concentration and behaviour in children with high levels of hyperactivity and/or inattention. This paper reports the protocol for the first 16-week, randomized, placebo-controlled, double-blind, parallel groups trial examining the efficacy and safety of CDRI 08 in male children aged 6–14 years with high levels of inattention and hyperactivity. The primary outcome variable will be the level of hyperactivity and inattention measured by the Conners’ Parent Rating Scale (CPRS). Secondary outcome variables include cognition, mood, sleep, and EEG. Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12612000827831. MDPI 2015-12-02 /pmc/articles/PMC4690059/ /pubmed/26633481 http://dx.doi.org/10.3390/nu7125507 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Kean, James D. Kaufman, Jordy Lomas, Justine Goh, Antionette White, David Simpson, David Scholey, Andrew Singh, Hemant Sarris, Jerome Zangara, Andrea Stough, Con A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) |
title | A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) |
title_full | A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) |
title_fullStr | A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) |
title_full_unstemmed | A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) |
title_short | A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) |
title_sort | randomized controlled trial investigating the effects of a special extract of bacopa monnieri (cdri 08) on hyperactivity and inattention in male children and adolescents: bachi study protocol (anzctrn12612000827831) |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690059/ https://www.ncbi.nlm.nih.gov/pubmed/26633481 http://dx.doi.org/10.3390/nu7125507 |
work_keys_str_mv | AT keanjamesd arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT kaufmanjordy arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT lomasjustine arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT gohantionette arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT whitedavid arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT simpsondavid arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT scholeyandrew arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT singhhemant arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT sarrisjerome arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT zangaraandrea arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT stoughcon arandomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT keanjamesd randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT kaufmanjordy randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT lomasjustine randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT gohantionette randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT whitedavid randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT simpsondavid randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT scholeyandrew randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT singhhemant randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT sarrisjerome randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT zangaraandrea randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 AT stoughcon randomizedcontrolledtrialinvestigatingtheeffectsofaspecialextractofbacopamonniericdri08onhyperactivityandinattentioninmalechildrenandadolescentsbachistudyprotocolanzctrn12612000827831 |